Device Brand Names Unnecessary In Open Payments Database, Industry Says
This article was originally published in The Gray Sheet
Executive Summary
Listing device brand names as part of physician payment disclosures to the Open Payments database would be difficult, and not meaningful, AdvaMed suggests. CMS has proposed updating its regulations to require device brand names to be included in Sunshine Act disclosures.